Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Head and neck cancer]

Y Inuyama1, S Fukuda, M Fujii

  • 1Dept. of Otolaryngology, Hokkaido University School of Medicine, Sapporo, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of interfering input from the peroneal nerve on tibial-nerve somatosensory evoked potential.

Electroencephalography and clinical neurophysiology·1992
Same author

Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes.

Genes & development·1992
Same author

[Clinical evaluation of intra-arterial methotrexate, vinblastine, doxorubicin and cis-platinum for bladder cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1992
Same author

[Clinical examination of acetated Ringer solution in patients with normal liver function and those with liver dysfunction].

Masui. The Japanese journal of anesthesiology·1992
Same author

Prevention of catheter-related sepsis during parenteral nutrition: effect of a new connection device.

JPEN. Journal of parenteral and enteral nutrition·1992
Same author

[Prognosis and treatment of non-Q-wave myocardial infarction].

Kokyu to junkan. Respiration & circulation·1992
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Recent advances in head and neck cancer chemotherapy show concurrent chemoradiotherapy is most promising for survival. While neo-adjuvant chemotherapy aids organ preservation, adjuvant chemotherapy may reduce distant relapse rates.

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Medical Oncology

Context:

  • Head and neck cancers represent a significant global health challenge.
  • Treatment strategies are evolving to improve patient survival and quality of life.
  • Chemotherapy plays a crucial role in various treatment modalities.

Purpose:

  • To review recent advancements in chemotherapy for head and neck cancer.
  • To evaluate the impact of different chemotherapy approaches on patient survival.
  • To focus on neo-adjuvant, concurrent chemoradiotherapy, adjuvant chemotherapy, and palliative chemotherapy.

Summary:

  • Neo-adjuvant chemotherapy did not improve survival but enhanced organ preservation in specific sites (larynx, maxilla).
  • Concurrent chemoradiotherapy is the most promising approach for locally advanced disease, improving local-regional control and survival.

Related Experiment Videos

  • Adjuvant chemotherapy, while not showing overall survival benefit, may reduce distant relapse rates. Palliative chemotherapy offers limited survival in advanced stages.

    • Impact:

    • Concurrent chemoradiotherapy is a cornerstone for locally advanced head and neck cancers.
    • Further research into adjuvant chemotherapy is warranted to mitigate distant relapse.
    • Optimizing chemotherapy sequencing can improve outcomes for head and neck cancer patients.